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Abstract
Skeletal muscle atrophy is a consequence of muscle inactivity resulting from denervation, unloading and immobility. It
accompanies many chronic disease states and also occurs as a pathophysiologic consequence of normal aging. In all these
conditions, ubiquitin-dependent proteolysis is a key regulator of the loss of muscle mass, and ubiquitin ligases confer
specificity to this process by interacting with, and linking ubiquitin moieties to target substrates through protein:protein
interaction domains. Our previous work suggested that the ubiquitin-protein ligase Nedd4-1 is a potential mediator of
skeletal muscle atrophy associated with inactivity (denervation, unloading and immobility). Here we generated a novel tool,
the Nedd4-1 skeletal muscle-specific knockout mouse (myoCre;Nedd4-1flox/flox) and subjected it to a well validated model of
denervation induced skeletal muscle atrophy. The absence of Nedd4-1 resulted in increased weights and cross-sectional
area of type II fast twitch fibres of denervated gastrocnemius muscle compared with wild type littermates controls, at seven
and fourteen days following tibial nerve transection. These effects are not mediated by the Nedd4-1 substrates MTMR4,
FGFR1 and Notch-1. These results demonstrate that Nedd4-1 plays an important role in mediating denervation-induced
skeletal muscle atrophy in vivo.
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Introduction
Skeletal muscle atrophy is a pathophysiologic consequence of
disease progression in multiple chronic illnesses such as cancer,
heart failure, HIV/AIDS and endstage pulmonary disorders. Loss
of muscle mass also occurs with muscle inactivity due to
denervation injury and immobility/unloading, and as a conse-
quence of normal aging or starvation. In all illnesses, skeletal
muscle atrophy impairs function, and enhances disease morbidity
[1–5].
Ubiquitin-mediated proteolysis was identified as a critical
regulator of skeletal muscle atrophy in several animal models of
disease [6–8]. In the ubiquitination process, the co-ordinated
action of several enzymes (E1, E2 and E3 ubiquitin ligases)
covalently attaches a single or branched ubiquitin moiety to lysine
residue(s) of the target substrate protein, which can serve as a
marker for regulated cellular degradation of the protein by the 26S
proteasome or the lysosome [9]. The E3 ligases are the key
enzymes that confer specificity to the system by binding and
linking ubiquitin moieties to the substrate, often through
protein:protein interaction domains [9]. There are two main
families of E3 ligases; HECT (homologous to E6-AP carboxy-
terminus) domain E3 ligases [10] and RING (Really interesting
new gene) finger ligases [11,12].
Two muscle specific ubiquitin ligases, the RING containing
atrogin-1/MAFbx and MuRF1, are involved prominently in the
development of skeletal muscle atrophy following metabolic insult
[13,14], as well as atrophy resulting from denervation and
immobility/unloading [15]. Both atrogin-1 and MuRF1 knock-
out mice are partially, but not fully, protected from the
development of skeletal muscle atrophy. We, and others, have
demonstrated increased expression of the HECT domain ubiqui-
tin ligase Nedd4-1 (Neural precursor cell expressed developmen-
tally down-regulated protein 4) in the muscle of rodents subjected
to models of hind-limb unloading and denervation induced muscle
atrophy [15,16]. In contrast to atrogin-1 and MuRF1, which
increase only in short term denervated muscle in rats, Nedd4-1
expression was sustained long term, suggesting that it plays a more
encompassing role in the induction of skeletal muscle atrophy [15].
Koncarevic et al. have demonstrated that in rodents, the increase
in Nedd4-1 occurs exclusively in muscle atrophy associated with
muscle inactivity, such as denervation, disuse and unweighting
[16]. We have also demonstrated that Nedd4-1 level is increased in
the atrophic muscles of individuals with severe Chronic Obstruc-
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tive Pulmonary Disease (COPD) [17]. We speculate that Nedd4-1,
like its RING E3 counterparts, is a critical E3 ligase in the
induction of inactivity induced muscle proteolysis, and that the
absence of Nedd4-1 in skeletal muscle will spare its atrophy
following insults associated with inactivity.
A second Nedd4 isoform, Nedd4-2, is expressed in human and
mouse [18–20]. Despite their structural similarities, Nedd4-1 and
Nedd4-2, for the most part, target distinct substrates and serve
distinct functions [21]. Nedd4-1 is the predominant skeletal muscle
isoform [19] and in Drosophila Nedd4-1 (dNedd4) was shown to
regulate neuromuscular synaptogenesis [22]. Nedd4-1 germline
deficient (complete null) mice are embryonic/perinatal lethal,
exhibiting cardiac and vascular defects, and abnormalities of
neurite development [23,24]. Nedd4-1 null embryonic mice also
demonstrate abnormalities in neuromuscular junction formation
[25] and possibly a skeletal muscle phenotype, developmental
muscle hypoplasia, although the relevance of this finding remains
uncertain since the Nedd4-1 null embryos demonstrate a global
reduction in body size and muscle size was not normalized to body
size [25]. Others have reported the muscle developmental delay in
Nedd4-1 null embryonic mice as part of a global developmental
delay [26]. The role of Nedd4-1 in post-natal muscle is unknown.
Our goal here was to assess the role of Nedd4-1 in the
development of denervation induced skeletal muscle atrophy in vivo
using a genetic (mouse) model. To this end, we generated Nedd4-1
skeletal muscle-specific knockout (Nedd4-1 SMS-KO) mice, and
subjected them to a well validated model of denervation induced
muscle atrophy. We report the Nedd4-1 SMS-KO mice demon-
strate partial protection from muscle atrophy, exhibiting heavier
denervated muscle weights and larger type II fibre cross sectional
areas compared to their wild type littermates. These findings show
that Nedd4-1 plays an important role in the regulation of
denervation- induced skeletal muscle atrophy in animals.
Materials and Methods
Generation of Nedd4-1 skeletal muscle-specific knockout
mice
Mice with a floxed Nedd4-1 allele (Nedd4-1flox/flox) reported in our
previous study [23] were crossed with a mouse line expressing Cre-
recombinase under the control of the mouse myogenin promoter
and the skeletal muscle specific enhancer of the mouse MEF2C
gene [myo-cre (myoCre) mouse, generously supplied by Dr. Eric
Olson, University of Texas, South Western] [27]. Both of these
regulatory elements are active only in the skeletal muscle lineage
from embryonic day (E) 8.5 to adulthood, thus allowing us to
generate a mouse line in which Nedd4-1 was deleted specifically
from skeletal muscle. Mice heterozygous for the floxed Nedd4-1
allele and for the myo-cre transgene (myoCre;Nedd4-1flox/+) were bred
to create Nedd4-1 SMS-KO (myoCre;Nedd4-1flox/flox) mice and control
littermates (myoCre;Nedd4-1+/+, Nedd4-1+/+ and Nedd4-1flox/flox) mice.
Experimental denervation model and muscle preparation
The well validated gastrocnemius muscle denervation model
[28] was employed and approved by the Research Ethics Board,
Hamilton Health Sciences Corporation, McMaster University
(AUP # 10-04-24). The study was carried out in strict accordance
with the recommendations of the Canadian Council on Animal
Care. The right tibial nerve was transected under inhalational
Halothane anaesthesia completely denervating the gastrocnemius
muscle in Nedd4-1 SMS-KO mice and littermate myoCre;Nedd4-1+/+
control mice at the age of three to five months. The proximal
portion of the tibial nerve was sutured to the superficial surface of
the biceps femoris muscle to prevent errant re-innervation of the
gastrocnemius muscle. The contralateral leg served as an internal
control in each animal. This manipulation permits full weight
bearing by the mouse on the both hind limbs during ambulation.
Mice were maintained under conditions of routine care for 1 or 2
weeks post-nerve transection. Subsequently, the mice were
sacrificed and the gastrocnemius muscles were harvested from
the operated experimental limb and contralateral control limb.
After rapid, atraumatic dissection and weighing, the muscle was
split and fixed in 10% buffered formalin or snap frozen in liquid
nitrogen. Fixed tissue was processed for immunohistochemistry
and morphometric measurements. Frozen muscle was used for
extraction of cellular protein.
Western Blotting
Total protein was extracted by homogenizing (Polytron PT
1200E, Kinematica, Lucerne, Switzerland) the muscle in Muscle
Lysis Buffer [5 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM
EGTA, 1 mM b-mercaptoethanol, 1% glycerol, PMSF (1 mM),
leupeptin, aprotinin (10 ug/ml each)] for 3630 sec. and homog-
enates were centrifuged at 16006g for 10 min at 4uC. The
supernatant was cleared by centrifuging further for 10 min at 4uC,
10,0006g. All fractions were quantified using the Pierce (Rock-
ford, IL, USA) BCA Protein Assay Kit and normalized for equal
loading for SDS-PAGE and Western blot analysis.
25 or 50 mg of muscle lysates were separated by SDS-PAGE,
transferred to nitrocellulose, Ponceau-S stained and immuno-
blotted. The commercial primary antibodies used included anti-
Nedd4-1 (BD-Biosciences, Franklin Lakes, NJ, USA, #611480), -
Hypoxanthine-guanine-phosphoribosyltransferase (HPRT; Ab-
cam, Cambridge, MA, USA #109021), -Pax-7 (Developmental
Studies Hybridoma Bank, DSHB, University of Iowa, Iowa City,
IA, USA), -Nedd4-2 (Cell Signalling Technologies, Danvers, MA,
USA, #4013), -Fibroblast Growth Factor Receptor 1 (FGFR1;
Abcam #824), -Notch-1 (Cell Signalling) and anti- Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH, Abcam, #8245)
antibodies. Secondary antibodies were Horseradish peroxidase
(HRP)-linked anti-rabbit, anti-mouse or anti-rat and protein bands
detected with Biorad ECL (Biorad Laboratories, Hercules, CA,
USA) or Immun Star Western C (Biorad Laboratories). Quanti-
fication of the chemiluminescent signal from Western blots was
performed with Bio-Rad Fluor S Max Acquisition System (Biorad
Laboratories) and Image Lab software (Biorad Laboratories).
The anti-MTMR4 (Myotubularin related protein 4) antibody
was generated in our laboratory against a Glutathione transferase
(GST)-fusion protein of the C terminal region of MTMR4
(RARELMSQQLKKPIATASS; aa 1172–1195, accession #
CAQ52069), that was purified from bacteria with glutathione
agarose beads, then subjected to thrombin cleavage to release the
MTMR4 specific peptide. As the peptide molecular weight is only
approx 3 kDa and we were unable to visualize the final product on
a Coomassie stained gel, we obtained confirmation of peptide size
with mass spectrometry analysis (data not shown). A polyclonal
antibody was generated in rabbit following injection of the purified
peptide. Specificity of the antibody was confirmed by assessing
pre-immune and post-immune serum on Western blotting of
HEK293 cell lysates untransfected and transfected with HA-
tagged MTMR4 cDNA (data not shown).
Immunohistochemistry and muscle morphometrics
Gastrocnemius muscles were fixed in 10% buffered formalin
phosphate for 24 hours at room temperature, rinsed in ethanol,
paraffin embedded and sectioned (10 mm thickness) on cross
section. The sections were rehydrated in a series of xylene and
ethanol washes and then endogenous peroxidases were quenched
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with a 30 min. incubation in 0.3% H2O2. Antigen retrieval was
performed by microwaving the sections in 10 mM sodium citrate,
pH 6.0, 365 min at 90% power (720 Watt oven). Sections were
blocked with Protein Block – Serum Free (Dako/Agilent,
Mississauga, Canada). Sections were rinsed and fibres were
immunostained using either anti-skeletal muscle myosin, fast
isoform antibody (MY-32, Sigma) specific to fast-twitch muscle
fibres, or anti-Pax-7 (Pax 7, Developmental Studies Hybridoma
Bank, University of Iowa, USA), a marker of muscle satellite cells/
myoblasts, followed by biotinylated secondary antibody and
streptavidin-HRP/DAB (Vectastain ABC Elite Peroxidase kit,
Vector Laboratories Inc., Burlingame, CA, USA). For a negative
control, the primary antibody was omitted during immunostain-
ing. Hematoxylin was used as a counterstain. Cross sectional areas
(CSA) of type I and type II fibres were determined using ImageJ
software (NIH) by 3 independent reviewers blinded to mouse
genotype. A minimum of 300 fibres per muscle were measured.
Primary Satellite cell/myoblast Isolation and Culture
Primary myoblast cultures were generated as previously
described [29]. Briefly, hindlimb muscles were dissected from
Nedd4-1 SMS-KO and littermate myoCre;Nedd4-1+/+ control mice,
and incubated in Dulbecco’s Modified Eagles Medium (Gibco
BRL, Rockville, MD, USA) with 2% (w/v) collagenase II (Gibco
BRL, Grand Island NY, USA) for 90 min at 37uC. Digested
muscle was washed in growth media (GM; Hams F10 media with
20% Fetal Bovine Serum, 5 ng/mL basic fibroblast growth factor,
1% penicillin/streptomycin) and dissociated into single myofibres
with repetitive trituration using a glass Pasteur pipette. To further
isolate satellite cells, myofibres were washed 2 more times
aggressively to remove adherent cells (satellite cells are situated
beneath the basal lamina). Satellite cells were liberated by further
digesting the myofibre fragments in 10 volumes of PBS, 0.5 U/mL
dispase (Invitrogen, Life Technologies, Grand Island NY, USA)
and 38 U/mL collagenase type II (US Biological, Swampscott,
MA, USA) for 30 min at 37uC with agitation. Fetal bovine serum
(1:10 by volume) was added to digests to block further enzymatic
reactions, followed by centrifugation at 5006g for 1 min to settle
debris. The resulting supernatant was filtered through a 50 micron
mesh, centrifuged at 10006g for 5 min to pellet satellite cells. The
cells were then re-suspended in GM and pre-plated onto a plastic
tissue culture dish in GM for 40 min to remove any remaining
fibroblasts (which adhere readily to plastic). Satellite cells were
transferred and cultured in GM to glass cover slips in 6 well plates
coated with lamin 5 ug/mL (Gibco, BRL) and 0.002% collagen
(Sigma) and grown at 37uC in 5% CO2.
Immunocytology
Myoblast cultures were fixed with 4% paraformaldehyde in PBS
for 15 min, washed with PBS and paraformaldehyde was
subsequently deactivated with 100 mM glycine in PBS for
10 min. Cells were washed, then permeabilized in buffer
containing 0.1% Triton X-100 diluted in PBS for 20 min at
room temperature (RT). Cells were washed with PBS and then
blocked with the addition of 5% BSA in PBS for 1 hour at RT.
Cells were labelled with rabbit anti-MyoD (Santa Cruz Biotech-
nologies, Santa Cruz CA, USA, sc-304) and mouse anti-Nedd4-1
(BD-Biosciences) antibodies for 1 hour at RT. The cells were then
washed with PBS and labeled with Alexa Fluor 2488 and 2568
secondary antibodies (Molecular Probes, Eugene, OR, USA) and
Hoechst nuclear stain in PBS for 1 hour. Samples were washed
with PBS, mounted and stored at 4uC until imaged.
Cellular fluorescence was visualized with an Olympus BX50
microscope (Olympus America, Center Valley, PA, USA) using
406magnification. Images were captured using CellSens Software
(Olympus America). TRITC and FITC filter sets were used to
visualize Nedd4-1 and MyoD expressing cells, respectively.
Statistical Analyses
Continuous data are reported as a mean and standard error.
Two way ANOVA was used to compare normalized measures
(muscle weights, fibre CSA, protein levels) between Nedd4-1 SMS-
KO and myoCre;Nedd4-1+/+ control mice at 1 and 2 weeks post
denervation. Differences in absolute measures (muscle weights or
fibre CSA) between Nedd4-1 SMS-KO and myoCre;Nedd4-1+/+
control innervated and denervated gastrocnemius at 1 week or 2
weeks were assessed by one way ANOVA followed by post-hoc
Bonferroni’s multiple comparison tests. Statistical significance was
assumed in all cases if p,0.05.
Results
Generation of Nedd4-1 SMS-KO mice
To confirm deletion of Nedd4-1 protein in the Nedd4-1 SMS-
KO skeletal muscle, we performed SDS-PAGE and Nedd4-1
Western blotting (WB) analysis of gastrocnemius muscle lysates
from Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ control
mice (Figure 1). The results reveal the absence of Nedd4-1 protein
in the Nedd4-1 SMS-KO muscle while a GAPDH loading control
remains unaltered (Figure 1A). When other tissues (heart, liver and
kidney) were examined, the amount of Nedd4-1 protein in Nedd4-1
SMS-KO and littermate control mice was equivalent in all tissues
(Figure 1B), demonstrating the skeletal muscle specificity of our
Nedd4-1 knockout. Furthermore, to ensure that the knock-out was
specific for Nedd4-1, expression of Nedd4-2 was confirmed in the
Nedd4-1 SMS-KO skeletal muscle (Figure 1A). These data validate
our genetic model and confirm the specificity of the Nedd4-1 null
phenotype in skeletal muscle.
Denervation increases Nedd4-1 protein expression
Previously we, and others, have shown increased Nedd4-1
expression in gastrocnemius muscles undergoing denervation or
unloading induced atrophy [15,16,30]. To confirm this phenom-
enon in our genetic mouse model, Nedd4-1 SMS-KO and
littermate MyoCre;Nedd4-1+/+ control mice underwent right tibial
nerve transection with the left hind limb serving as control.
Gastrocnemius muscles were harvested 1 and 2 weeks post-
denervation, weighed and lysed for Western Blotting (Figure 2A,
2B). Nedd4-1 expression in the denervated compared to the
contralateral control muscle of the control mice was increased
dramatically. Nedd4-1 is absent from the Nedd4-1 SMS-KO
control gastrocnemius (as noted above, Figure 1), but trace Nedd4-
1 expression becomes evident with denervation.
Trace Nedd4-1 expression in denervated gastrocnemius
muscle of Nedd4-1 SMS-KO results from satellite cell/
myoblast proliferation
To determine the source of the trace Nedd4-1 expression in the
denervated gastrocnemius muscle, we assessed muscle satellite
cells/myoblasts for Nedd4-1 protein expression. Quiescent satellite
cells/myoblasts initiate proliferation in a reparative response to
denervation injury, increasing from about 1%, to up to 10%, of all
muscle cells [31]. Our knockout design does not delete Nedd4-1
from skeletal muscle satellite cells/myoblasts. During embryogen-
esis, expression of the transcription factors MyoD and Myf5
specify mesodermal precursor cells to the myogenic lineage,
generating proliferative myoblasts [32]. Subsequent expression of
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myogenin and MRF4 induce terminal differentiation of myoblasts
to mononucleated myocytes, which then fuse together to form
multinucleated muscle fibres. During skeletal muscle development,
a subpopulation of myoblasts, known as satellite cells, fail to
differentiate but remain associated with the myofibres and retain
the capacity to proliferate and differentiate so as to regenerate
skeletal muscle post-natally [32]. Since Cre-recombinase expres-
sion in our mice is under the control of the myogenin promoter,
Nedd4-1 should still be expressed post-natally in the quiescent
satellite cells and proliferating myoblasts of Nedd4-1 SMS-KO
mice, because myogenin is not yet expressed in these progenitor
cells. Indeed, we were able to demonstrate the co-expression of
Nedd4-1 and myoD in cultured myoblasts derived from the Nedd4-
1 SMS-KO mice (Figure 3). We additionally demonstrate
increased expression of the satellite cell/myoblast marker Pax-7
[32] in the denervated gastrocnemius (Figures 4A, 4B and 4C) of
both Nedd4-1 SMS-KO and littermate control mice, in keeping
with the known activation of satellite cell/myoblast proliferation
following denervation [33,34]. These data together support the
conclusion that trace Nedd4-1 expression induced in the
denervated gastrocnemius of Nedd4-1 SMS-KO mice likely results
from associated satellite cell/myoblast proliferation.
Nedd4-1 SMS-KO mice are partially protected against
denervation atrophy
As a measure of muscle sparing, denervated and control
innervated gastrocnemius muscles were harvested 1 and 2 weeks
post nerve transection, weighed, fixed, cut on cross-section and
immunostained for fast twitch myosin to identify type I and type II
fibres.
At baseline, the Nedd4-1 SMS-KO mice are slightly smaller
than, and the gastrocnemius muscle weighs less than, that of
littermate control mice (Figure 5A). However, there is no
difference in the muscle mass when normalized to body weight
(Figure 5B).
Denervated gastrocnemius muscle weights, normalized to the
weight of the contralateral limb control muscle, were significantly
greater in Nedd4-1 SMS-KO compared to littermate MyoCre;Nedd4-
1+/+ mice at both 1 and 2 weeks post tibial nerve transection
(Figure 5C), demonstrating an attenuated atrophic response in the
Nedd4-1 null muscle. Similarly, the type II fibre CSA was
significantly larger in the denervated gastrocnemius muscle of
Nedd4-1 SMS-KO compared to control myoCre;Nedd4-1+/+ mice
(Figure 6). This is despite the fact that control innervated
myoCre;Nedd4-1+/+ gastrocnemius type II fibre CSA was larger than
that of Nedd4-1 SMS-KO mice (Figure 6B and 6C). Denervation
induces a fibre type switch from type I to type II fibres, and as a
result an inadequate number of type I fibres was available for
measurement in the formalin fixed portions of denervated
gastrocnemius.
Levels of the Nedd4-1 substrates MTMR4, Notch-1 and
FGFR1, are not altered by loss of Nedd4-1 in muscles
To identify potential Nedd4-1 muscle substrates that regulate
the loss of muscle mass we focused on known Nedd4-1 substrates
that have been reported to demonstrate decreased protein levels in
denervated and/or unloaded or immobilized muscle, and identi-
fied potentially three; MTMR4, FGFR1 and Notch-1 [16,35,36].
We reasoned that if Nedd4-1 signalled downstream via either
MTMR4, FGFR1 or Notch-1 to induce muscle atrophy, then
these protein(s) would be protected from degradation in the
denervated gastrocnemius muscle of Nedd4-1 SMS KO mice.
We found that levels of both MTMR4 and FGFR1 proteins
decreased in the denervated gastrocnemius muscle of control mice
coincident to the increase in Nedd4-1 (Figures 7A and 7B), but
there was no attenuation of that decrease for either protein in the
denervated gastrocnemius of Nedd4-1 SMS-KO mice, suggesting
that neither MTMR4 nor FGFR1 are substrates involved in
Nedd4-1’s mediation of denervation induced muscle atrophy. In
contrast, cleaved Notch-1 demonstrated an increase in the 2 week
denervated gastrocnemius compared to control muscle (Figures 7A
and 7B) and the extent of this increase was similar between Nedd4-
1 SMS-KO and littermate control mice, again suggesting that
Notch-1 does not serve as a substrate in Nedd4-1’s induction of
skeletal muscle atrophy. Notch-1 full length (FL) was not
detectable in muscle lysates with several Notch-1 antibodies tested
(data not shown).
Discussion
In the present study we generated a novel genetic tool, the
Nedd4-1 SMS-KO mouse, to assess the role of Nedd4-1 in the loss
of skeletal muscle mass. We subjected the mice to a well-validated
model of denervation-induced skeletal muscle atrophy. We showed
heavier weights and larger type II fibre cross sectional area in
denervated relative to control gastrocnemius muscle of the Nedd4-1
SMS-KO mice, demonstrating that the ubiquitin ligase Nedd4-1
Figure 1. Nedd4-1 protein is absent from MyoCre;Nedd4-1flox/flox
(Nedd4-1 SMS-KO) skeletal muscle. (A) SDS-PAGE and Nedd4-1
Western blotting (WB) of 50 mg of gastrocnemius muscle lysates from
representative Nedd4-1 SMS-KO mice (M4, M5, M6) and littermate
MyoCre;Nedd4-1+/+ control mice (M1, M2, M3) reveal the absence of
Nedd4-1 in the Nedd4-1 SMS-KO muscle. Nedd4-2 protein remains
equally expressed in the muscle of Nedd4-1 SMS-KO and MyoCre;Nedd4-
1+/+ control mice. GAPDH served as a loading control. (B) WB of heart,
liver and kidney protein lysates reveal equal Nedd4-1 protein in these
tissues in the Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ control
mice. GAPDH served as a loading control for all blots; liver lysate is
shown as a representative blot.
doi:10.1371/journal.pone.0046427.g001
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participates in the development of denervation-induced skeletal
muscle atrophy.
Others have also interrogated the role of Nedd4-1 in muscle
proteolysis and reported that acute over-expression of recombi-
nant Nedd4-1 via cDNA electrotransfer into muscle did not induce
myofibre atrophy at seven days in weight bearing rats, nor did
over-expression of a catalytically inactive dominant negative
Nedd4-1 rescue myofibres from atrophy induced by seven days
of unloading [16]. The reason for these findings, which are
contradictory to our observations, is not clear. We speculate they
may result from the use of a dominant negative, as opposed to a
genetic or knockdown approach and/or inadequate levels or
duration of Nedd4-1 expression in vivo. With exogenous expres-
sion, the early and single seven day time point of assessment may
have been inadequate to observe the Nedd4-1 effect, which
remains up-regulated in muscle for many weeks following
denervation [15]. The generation of our genetic mouse model
here has provided us with a unique tool with which to bypass these
limitations and demonstrate a positive role for Nedd4-1 in the
mediation of denervation induced skeletal muscle atrophy.
Figure 2. Denervation induces increased Nedd4-1 protein expression in gastrocnemius muscle. Nedd4-1 SMS-KO and littermate
MyoCre;Nedd4-1+/+ control mice underwent right tibial nerve transection with the left hind limb serving as control. Western blotting (WB) of 50 mg
gastrocnemius protein lysates denervated for 1 week (A) and 2 weeks (B) show increased Nedd4-1 protein in the denervated (Den) compared to the
contralateral control (Con) muscle of MyoCre;Nedd4-1+/+ mice. Nedd4-1 is absent from the Nedd4-1 SMS-KO control gastrocnemius, but trace Nedd4-1
becomes evident with denervation. Representative blots are shown (n= 8 to 9 mice/cohort).
doi:10.1371/journal.pone.0046427.g002
Figure 3. Satellite cells/myoblasts isolated from Nedd4-1 SMS-KO mice express Nedd4-1. Muscle satellite cells/myoblasts were isolated
from Nedd4-1 SMS-KO mice and littermateMyoCre;Nedd4-1+/+ control mice and maintained in culture. Cultures were immunostained for Nedd4-1 (red)
and MyoD (green) and nuclei were visualized with Hoechst (blue). MyoD, a specific marker of myoblasts, is expressed in nuclei; Nedd4-1 is
predominantly cytoplasmic. Myoblasts derived from both Nedd4-1 SMS-KO and littermate control mice demonstrate co-expression of MyoD and
Nedd4-1. Immunostaining with 2u antibodies alone served as a negative control and did not demonstrate non-specific staining (data not shown).
Scale bar shown= 50 mm.
doi:10.1371/journal.pone.0046427.g003
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Figure 4. Satellite cell/myoblast population is increased in denervated gastrocnemius muscle. (A) Cross sections of gastrocnemius
muscle from Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ mice were immunostained for the satellite cell/myoblast marker Pax 7 (brown nuclei,
indicated by white arrows). Myonuclei are counterstained purple with hematoxylin. There is an apparent increase in satellite cell number in the
denervated gastrocnemius of both Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ control mice. (B) Similarly, representative Western blots (WB) of
gastrocnemius protein lysates denervated for 1 week (left panel) and 2 weeks (right panel) show increased expression of Pax 7 in the denervated
(Den) compared to the contralateral control (Con) muscle of Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ mice. HPRT served as loading control.
(C) The chemiluminescent signal was quantified and Pax-7 protein levels were normalized to corresponding HPRT levels (lane matched). Normalized
Pax-7 levels in denervated (Exp) muscle were expressed as a fraction of the normalized Pax-7 level in control (Con) muscle and these values are
depicted in the graph. Pax-7 is significantly increased in the denervated gastrocnemius muscle of both Nedd4-1 SMS-KO and MyoCre;Nedd4-1+/+ mice
at both 1 and 2 weeks post-tibial nerve transection (n = 6 mice/group, p,0.05), but there is no difference in the magnitude of the increase between
Nedd4-1 SMS-KO and MyoCre;Nedd4-1+/+ mice. Data are presented as the mean 6 SEM.
doi:10.1371/journal.pone.0046427.g004
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Figure 5. Nedd4-1 SMS-KO gastrocnemius muscle weights are partially spared from denervation induced atrophy. (A) Total body
weights (left panel) and gastrocnemius muscle weights (right panel) of Nedd4-1 SMS-KO and littermate MyoCre;Nedd4-1+/+ control mice. Nedd4-1 SMS-
KO mice are slightly smaller, and their gastrocnemius muscle weigh less, than littermate controls (n = 16 pairs, * p,0.05). (B) There is no difference in
the basal gastrocnemius muscle mass between the Nedd4-1 SMS-KO and control mice when muscle weight is normalized to body weight p.0.05). (C)
Nedd4-1 SMS-KO and littermate control mice underwent right tibial nerve transection, denervating the gastrocnemius muscle, with the intact left
hind limb serving as internal control. Denervated gastrocnemius muscle weights are normalized to the weight of the contralateral control muscle.
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The contribution of Nedd4-1 to the regulation of denervation
induced muscle atrophy appears to be smaller than that provided
by either atrogin-1 or MuRF1. Genetic deletion of either of these
ligases under similar conditions resulted in the retention of a larger
muscle mass at fourteen days post denervation, when compared to
our results here with Nedd4-1 [13]. The influence of Nedd4-1 on
muscle may be more extensive than what we demonstrate at this
time, given that Nedd4-1 expression is retained in satellite cells/
Denervated muscle of Nedd4-1 SMS-KO (solid line, closed squares) mice demonstrates an attenuated atrophic response weighing significantly more
than in MyoCre;Nedd4-1+/+ (dashed line, open circles) mice at 1 and 2 weeks post denervation, (*p,0.05, n = 8 or 9 mice/cohort. Data are presented as
the mean 6 SEM).
doi:10.1371/journal.pone.0046427.g005
Figure 6. Nedd4-1 deletion attenuates denervation induced decreases in gastrocnemius Type II fibre cross-sectional area. (A) Cross
sections of denervated and control gastrocnemius muscle of Nedd4-1 SMS-KO and MyoCre;Nedd4-1+/+ (littermate control) mice were immunostained
with an anti-fast twitch myosin antibody and counterstained with hematoxylin. Fast twitch type II fibres stain brown, and slow twitch type I fibres
stain light purple. Representative cross sections from control and 2 week denervated gastrocnemius muscle from both Nedd4-1 SMS-KO and
littermate control mice are shown. (B) Histograms of type II fibre cross sectional areas (CSA) for control innervated (left panel), 1 week denervated
(middle panel) and 2 week denervated (right panel) gastrocnemius muscles in Nedd4-1 SMS-KO (solid line, closed squares) and littermate control
(dashed line, open circles) mice are shown. (C) At baseline, Nedd4-1 SMS-KO gastrocnemius type II fibre CSA is smaller than that of MyoCre;Nedd4-1+/+
mice (*). Following denervation, there is a significant decrease in type II fibre CSA for both cohorts of mice. However the CSA of Nedd4-1 SMS-KO
muscle fibres denervated for 2 weeks is significantly larger than fibres of MyoCre;Nedd4-1+/+ mice (**) denervated for 2 weeks. (D) Similarly, when Type
II fibre CSA in denervated gastrocnemius muscle is normalized to CSA in the contralateral control muscle, type II fibres are significantly larger in
Nedd4-1 SMS-KO (solid line, closed squares) mice compared to MyoCre;Nedd4-1+/+ (dashed line, open circles) mice at both 1 week and 2 weeks post
denervation. A minimum of 300 myofibres/muscle was measured, (** and *p,0.05, n = 8 or 9 mice/cohort. Data are presented as the mean 6 SEM).
doi:10.1371/journal.pone.0046427.g006
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Figure 7. Levels of MTMR4 and FGFR-1 are not maintained in the denervated gastrocnemius of Nedd4-1 SMS-KO mice, while
cleaved Notch-1 expression is increased. (A) Representative Western blots of MTMR4, FGFR1, cleaved Notch-1 (Notch-1 ICD) and HPRT (as a
loading control) in protein lysates from denervated gastrocnemius muscle (Den) or the contralateral control gastrocnemius (Con) muscle in Nedd4-1
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myoblasts in our Nedd4-1 SMS KO mice. Deletion of Nedd4-1
from the satellite cell population may enhance the satellite cell/
myoblast proliferative response to denervation, thus further
inhibiting the development of atrophy, but we were unable to
assess this phenomenon in our genetic model. Nonetheless, given
that the individual absence of each of Nedd4-1, atrogin-1 or
MuRF1 was insufficient to provide complete protection against
muscle atrophy, it is likely that the co-ordinated activity of these
three ligases together with other proteolytic systems is necessary to
mediate the loss of muscle mass following denervation.
We found the deletion of Nedd4-1 from skeletal muscle
provided protection from denervation induced atrophy early post
denervation (seven days), like atrogin-1 and in contrast to MuRF1
which demonstrates a delayed protective effect, being evident at
only fourteen days post denervation [13]. The varied temporal
effects of these E3 ligases may result from the different
downstream substrates that each engages. MuRF1 ubiquitinates
several muscle contractile/structural proteins, resulting in prote-
olysis of primarily thick filament fibres [37–39]. In contrast, it
appears that atrogin-1 mediates skeletal muscle atrophy by
ubiquitinating proteins that stimulate protein synthesis and muscle
precursor cell proliferation and differentiation, the eukaryotic
initiation factor eIF3-f and MyoD respectively, marking them for
proteasome-mediated proteolysis [40,41]. To identify the sub-
strates that Nedd4-1 targets to promote the induction of
denervation induced skeletal muscle atrophy we focused on
known Nedd4-1 substrates that demonstrate decreased levels in
denervated and/or unloaded or immobilized muscle; MTMR4,
which we identified previously [35], FGFR1 [42] and Notch-1
[16].
MTMR4 belongs to a family of dual specificity phosphatases,
the myotubularins, which regulate phosphoinositol metabolism in
early endosomes, thereby regulating endocytosis and trafficking of
proteins, including growth factor receptors [43–46]. Knockout of
the related MTM1 results in a progressive atrophic myopathy
starting at a few weeks after birth, suggesting MTM1 is required
for muscle structural maintenance [47]. Ectopic over-expression of
FGFR1 in mouse gastrocnemius by electroporation significantly
inhibited inactivity-induced atrophy, and FGFR1 is increased in
myofibres that are partially resistant to inactivity-induced atrophy
[36]. While we observed decreased MTMR4 and FGFR1 protein
levels in the denervated gastrocnemius muscle of control mice
coincident with the increase in Nedd4-1, in keeping with the
possibility that Nedd4-1 mediated ubiquitination of these target
proteins is causally associated with the loss of muscle mass, this
does not appear to be the case as we found no attenuation of this
decrease in MTMR4 and FGFR1 protein levels in the denervated
gastrocnemius of Nedd4-1 SMS-KO mice.
Notch-1 is a transmembrane receptor protein that is sequen-
tially cleaved upon ligand binding, releasing its ‘‘activated’’
intracellular domain, which translocates from the cytosol to the
nucleus to influence transcription [48]. In muscle satellite cells
Notch-1 positively regulates proliferation, and decreased expres-
sion of Notch-1 coincides with the onset of terminal differentiation
to myocytes [29,49]. A role for Notch-1 in mature muscle fibres
has not yet been elucidated.
The response of Notch-1 to denervation has been disputed. One
study demonstrates both denervation and unloading decrease
Notch-1 (full length and cleaved) protein levels in muscle seven
days post intervention [16], while another recent study reports an
increase in cleaved Notch-1 protein in muscle, seven and 35 days
following denervation injury [50]. Our own work here similarly
shows that Notch-1 is increased in denervated muscle, but there
was no difference in the magnitude of the cleaved Notch-1
increase between Nedd4-1 SMS-KO and littermate control mice.
This increase in Notch-1 may reflect an increase in satellite cell
proliferation. While denervation of skeletal muscle results in
myofibre proteolysis, the muscle concurrently mounts a reparative
response. Within 48 hours of denervation, satellite cells/myoblasts
begin to activate, proliferate and then differentiate to myocytes
that fuse to form myotubes, or bridge myofibres, in an attempt at
regeneration [33,34,51]. With prolonged denervation (several
weeks to months in rats), the satellite cell regenerative response
eventually becomes exhausted [51,52]. At both one and two weeks
post tibial nerve transection, we demonstrated a marked increase
in the satellite cell/myoblast marker Pax-7 [32] in the denervated
gastrocnemius muscle of both Nedd4-1 SMS-KO and littermate
control mice, in keeping with the satellite cell proliferative response
to denervation. Thus, we currently find no evidence of Nedd4-1
engaging Notch-1 to mediate denervation induced skeletal muscle
atrophy. The downstream mechanism by which Nedd4-1
contributes to the induction of denervation induced skeletal
muscle atrophy currently remains unknown.
In conclusion, using a novel and unique genetic tool, the Nedd4-
1 SMS-KO mouse, we have demonstrated that the ubiquitin ligase
Nedd4-1 participates in the positive regulation of denervation
induced skeletal muscle atrophy.
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